Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20015299HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20067886HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20015177HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20026584HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20016513HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20030798HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS44020094HTLV-1ENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS44022969HTLV-1ENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TCGA Plot Options
Drug Information
GeneRXRA
DrugBank IDDB01436
Drug NameAlfacalcidol
Target IDBE0000412
UniProt IDP19793
Regulation Type
PubMed IDs20947021
CitationsZhang J, Chalmers MJ, Stayrook KR, Burris LL, Garcia-Ordonez RD, Pascal BD, Burris TP, Dodge JA, Griffin PR: Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer. Structure. 2010 Oct 13;18(10):1332-41. doi: 10.1016/j.str.2010.07.007.
GroupsApproved; Nutraceutical
Direct ClassificationVitamin D and derivatives
SMILESCC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])C(CCC[C@]12C)=CC=C1C[C@@H](O)C[C@H](O)C1=C
Pathways
PharmGKBPA164746469
ChEMBLCHEMBL1601669